Additionally, AR transcriptional activity is frequently co-opted by gene fusion events during prostate cancer (PCa) development and progression, as exemplified by AR-dependent ERG overexpression caused by fusion of the ERG gene body to the AR-regulated TMPRSS2 promoter (2). This evidence concerns the gene AR and prostate carcinoma.